PHILLIS RUTT: Open Payments
NPI 1447564109 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 43 payments from 20 companies in 2025. Trend: 2023 $547 · 2024 $796 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $163 |
| Novo Nordisk Inc | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| ABBVIE INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $61 |
| Astellas Pharma US Inc | 2 | $54 |
| ABIOMED | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $38 |
Products named: AIRSUPRA, PREVNAR 20, NURTEC ODT, REXULTI, Veozah, UBRELVY, Kerendia, TZIELD.
Industry payments across CO — which companies pay providers there.
